Back to search results

Church-based Health Intervention for Cardiovascular Health

This study, called CHERISH, is looking at ways to reduce racial differences in heart disease (cardiovascular disease or CVD) risk, especially in Black communities in Louisiana. It will test a program led by community health workers (CHWs) within churches. This program will use recommended lifestyle changes and medical treatments for conditions like high blood pressure (hypertension), diabetes, and high cholesterol (hypercholesterolemia). The study wants to see if this church-based approach can lower your estimated risk of heart disease over 18 months. You may be able to join if you are 40 or older, connected to a participating church, and have three or more CVD risk factors like being a smoker or overweight. The study aims to enroll 812 people.

Study design
This is an interventional study comparing two strategies for delivering health interventions, with a planned enrollment of 812 participants.
What's involved
Participants will receive health coaching on lifestyle changes and medication adherence, participate in church-based exercise and weight loss programs, and monitor their blood pressure over 18 months.
Compensation
Not stated in the trial record.
Follow-up
Your estimated heart disease risk will be measured at the beginning and again at 18 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06065098

Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health

Active, Not Recruiting
NAAges 40+InterventionalPrevention
Tulane University
~812 participants
Updated 2026-06-01 on ClinicalTrials.gov
What's tested:Evidence-based interventions recommended by the 2019 ACC/AHA Guideline on the Primary Prevention of CVD

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Difference in change in estimated atherosclerotic cardiovascular disease (ASCVD) risk score
Measured over Measured from baseline to 18 months
+1 more outcome measured

Conditions

Cardiovascular Diseases
Hypertension
Diabetes
Hypercholesterolemia

Explore related trials

Cardiovascular DisorderDiabetes MellitusHypercholesterolemiaHypertension

Where it's being run

1 sites across 1 states
Louisiana1

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Men or women aged ≥40 years
Community members associated with the participating churches (church members and their families and friends)
Individuals with three or more CVD risk factors (out of seven):
Current smoker
Overweight or obese (BMI ≥25 kg/m2)
Insufficient physical activity (\<150 minutes/week moderate intensity or \<75 minutes/week vigorous intensity)
Healthy diet score of \<4 components
Total cholesterol ≥200 mg/dL
Blood pressure ≥130/80 mmHg
Fasting plasma glucose ≥100 mg/dL
Willing and able to participate in the intervention

Exclusion

No prior hospitalization in the last 3 months for chronic heart failure or heart attack.
No current diagnosis of cancer requiring chemotherapy or radiation therapy
No stage-5 chronic kidney disease requiring chronic dialysis, or transplant.
Not pregnant or planning to become pregnant in the next 18 months.
No plans to move out of the New Orleans metropolitan area during the next year.

What this trial measures

  • Difference in change in estimated atherosclerotic cardiovascular disease (ASCVD) risk scoreMeasured from baseline to 18 months

    The ACC/AHA ASCVD risk score will be calculated using the pooled population cohort equation based on age (years), total cholesterol (mg/dL), high-density lipoprotein (HDL)-cholesterol (mg/dL), antihypertensive medication use, systolic BP (mmHg), current smoking status, and diabetes status. The risk score ranges from 0% to 100%.

  • Fidelity summary scoreMeasured at 6, 12, and 18 months

    The fidelity summary score is composed of the following key implementation strategy components: proportion of assigned health education sessions attended in all participants, proportion of assigned discussion sessions attended in all participants, proportion of recommended minutes of physical activity completed in all participants, proportion of days per week that fruits/vegetables are eaten as recommended in all participants, proportion of recommended home BP monitoring completed in patients with hypertension, proportion of required provider visits attended in all patients, and proportion of antihypertensive, antidiabetic, and statin medications taken in patients with hypertension or diabetes, or those who are eligible for statin treatment, respectively.